Also trades as: 4516.T (JPX) · $vol 8M · NPPNY (OTC) · $vol 0M

$23.50

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · $1.6B mcap · 47M float · 0.0000% daily turnover · Short 83% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$171.8B +7.2% ▲

5Y CAGR: +7.1%

Gross Profit

$114.0B +4.5% ▲

5Y CAGR: +9.7%

Operating Income

$33.2B -6.2% ▼

5Y CAGR: +4.9%

Net Income

$29.9B -8.1% ▼

5Y CAGR: +8.9%

EPS (Diluted)

$444.19 -8.1% ▼

5Y CAGR: +8.9%

EBITDA

$39.9B -5.6% ▼

5Y CAGR: +6.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$137.5B	$144.2B	$148.3B	$160.2B	$171.8B
YoY Growth	+12.8%	+4.9%	+2.8%	+8.1%	+7.2%
Cost of Revenue	$50.2B	$56.0B	$50.2B	$51.1B	$57.8B
Gross Profit	$87.3B	$88.2B	$98.0B	$109.1B	$114.0B
Gross Margin	63.5%	61.2%	66.1%	68.1%	66.4%
R&D Expenses	$22.9B	$24.1B	$31.7B	$34.3B	$36.9B
SG&A Expenses	$31.3B	$33.9B	$34.0B	$38.0B	$43.8B
Operating Expenses	$54.3B	$58.1B	$66.6B	$73.7B	$80.8B
Operating Income	$32.9B	$30.0B	$31.4B	$35.5B	$33.2B
Operating Margin	24.0%	20.8%	21.2%	22.1%	19.3%
Interest Expense	$119M	$136M	$329M	$145M	$167M
Income Before Tax	$33.3B	$30.5B	$33.6B	$36.1B	$36.7B
Tax Expense	$8.3B	$7.7B	$7.8B	$3.6B	$6.8B
Net Income	$25.0B	$22.8B	$25.9B	$32.6B	$29.9B
Net Margin	18.2%	15.8%	17.4%	20.3%	17.4%
EPS (Diluted)	$370.97	$338.70	$383.82	$483.26	$444.19
EBITDA	$38.0B	$35.7B	$36.3B	$42.3B	$39.9B
Shares Outstanding	67M	67M	67M	67M	67M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$39.1B	$40.2B	$42.0B	$38.9B	$39.5B	$40.7B	$47.5B	$43.9B
Cost of Revenue	$12.6B	$12.3B	$13.9B	$12.3B	$12.7B	$12.9B	$16.7B	$15.5B
Gross Profit	$26.5B	$27.9B	$28.1B	$26.6B	$26.9B	$27.8B	$30.8B	$28.4B
Gross Margin	67.7%	69.4%	67.0%	68.4%	68.0%	68.4%	64.9%	64.6%
R&D Expenses	$7.5B	$9.2B	$6.8B	$10.8B	$6.2B	$8.6B	$8.4B	$13.8B
SG&A Expenses	$9.2B	$8.8B	$9.5B	$10.4B	$10.0B	$10.5B	$11.4B	$11.9B
Operating Expenses	$16.7B	$18.0B	$16.3B	$21.2B	$16.8B	$19.1B	$19.8B	$25.7B
Operating Income	$9.8B	$9.9B	$11.8B	$5.4B	$10.1B	$8.7B	$11.1B	$2.7B
Operating Margin	25.0%	24.5%	28.0%	13.8%	25.5%	21.5%	23.3%	6.1%
Interest Expense	$31M	$1M	$0	$373K	$319K	$56M	$19M	$46M
Income Before Tax	$11.4B	$6.8B	$15.2B	$2.7B	$10.5B	$9.7B	$13.2B	$3.3B
Tax Expense	$1.1B	$678M	$3.1B	-$1.3B	$2.2B	$2.0B	$3.1B	-$646M
Net Income	$10.3B	$6.1B	$12.2B	$4.0B	$8.3B	$7.6B	$10.1B	$3.9B
Net Margin	26.2%	15.2%	29.0%	10.3%	20.9%	18.7%	21.2%	8.9%
EPS (Diluted)	$152.40	$90.68	$180.76	$59.45	$122.52	$113.00	$149.74	$57.52
EBITDA	$12.5B	$8.3B	$16.4B	$4.2B	$11.7B	$11.4B	$14.9B	$4.4B
Shares Outstanding	67M	67M	67M	67M	67M	67M	67M	68M

NPNKF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet